STOCK TITAN
  1. Home
  2. Sec-filings
  3. TTNP
  4. [DEFM14A] TITAN PHARMACEUTICAL INC Merger Proxy Statement

[DEFM14A] TITAN PHARMACEUTICAL INC Merger Proxy Statement

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
DEFM14A
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock TTNP logo
Titan Pharmaceut

NASDAQ:TTNP

TTNP Rankings

#10777 Ranked by Market Cap
N/A Ranked by Dividends

TTNP Latest News

Jun 27, 2025
Titan Pharmaceuticals Announces $600,000 Private Placement of Convertible Preferred Stock
Jun 3, 2025
Titan Pharmaceuticals Announces Filing of Registration Statement for Proposed Business Combination with TalenTec Sdn. Bhd.
Apr 11, 2025
Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock
Nov 27, 2024
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
Aug 19, 2024
Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd.

TTNP Latest SEC Filings

Jun 27, 2025
[8-K] TITAN PHARMACEUTICAL INC Reports Material Event
Jun 18, 2025
[8-K] TITAN PHARMACEUTICAL INC Reports Material Event

TTNP Stock Data

6.11M
941.55k
45.47%
0.33%
1.4%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SAN FRANCISCO